Pemafibrate and Telmisartan are medications primarily used to manage cholesterol and blood pressure, respectively. The study ...

By targeting underlying synovitis, the novel intra-articular liraglutide formulation 4P004 aims to bridge the gap between transient symptom relief and disease modification in knee OA.

The Company also welcomes Mr. John Duffy to his new role as Product Consultant and wishes to thank Mr. Duffy for his contributions to date. Previously, Mr. Duffy was Chief Executive Officer of the ...

Data showcase advances across oncology pipeline including pan-mutant BRAF, CBL-B and AURKA programsPresentations reinforce potential of degraders ...

LAPNET-01 Phase 1b study shows netrin-1 blockade may overcome and prevent chemoresistance in patients with pancreatic ductal adenocarcinoma (PDAC) with locally advanced PDAC (LAPC) NP137 is the ...

H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $74 billion of capital under management, is ...

SlMYB32 was identified as a repressor regulating phenylpropanoid pathway. CRISPR/Cas9-mediated mutagenesis of SlMYB32 results ...

Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzdTM ("unbuzzd") — the scientifically-proven and game-changing beverage proven to accelerate alcohol metabolism, restore ...

The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the ...

On Saturday, with podcaster and psychedelics fan Joe Rogan standing over his shoulder, President Trump signed an executive ...

Margarita L. Dubocovich, PhD, has been honored by the Association for Clinical and Translational Science (ACTS) as a member of the inaugural cohort of Fellows of ACTS (FACTS).